Legal & General Group PLC V Tv Therapeutics Inc. Transaction History

Legal & General Group PLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 12, 2021	SELL	$2.27 - $3.44 $4,383 - $6,642	-1,931 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$1.74 - $3.19 $3,359 - $6,159	1,931 New	1,931 $4,000
Q2 2018 Aug 10, 2018	SELL	$0.71 - $4.04 $630 - $3,587	-888 Closed	0 $0
Q4 2017 Feb 13, 2018	BUY	$3.9 - $7.77 $3,463 - $6,899	888	888 $5,000

243K

Ticker VTVT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 81,483,600
Market Cap $1.43B
Description
vTv Therapeutics Inc., a clinical-stage biopharmaceutical company, focuses on the development of orally administered treatments for diabetes. The company is developing TTP399, an orally administered, small molecule, and liver-selective glucokinase activator for the treatment of type 1 diabetes; and HPP737, an orally administered non-CNS penetran...

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

Stay updated on Legal & General Group PLC with notifications on news.